[Leflunomide in combination with TNF-blockers for Methotrexate intolerance].
Krüger
K
K
Praxiszentrum St. Bonifatius, St. Bonifatius Str. 5, 81541 München. Klaus.Krueger@med.uni-muenchen.de
Manger
B
B
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007555:Isoxazoles / Q000008:administration & dosage*; D000077339:Leflunomide; D008727:Methotrexate / Q000627:therapeutic use*; D000079424:Tumor Necrosis Factor Inhibitors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007555:Isoxazoles; D000079424:Tumor Necrosis Factor Inhibitors; D000077339:Leflunomide; D008727:Methotrexate